Michael R. Grever
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 28
- Chronic Lymphocytic Leukemia Research 25
-
- Lymphoma Diagnosis and Treatment 14
- Co-authors
- Saul A. Schepartz (2 shared papers)B A Chabner (1 shared paper)Eric H. Kraut (4 shared papers)Bertha A. Bouroncle (2 shared papers)John C. Byrd (7 shared papers)Neil E. Kay (2 shared papers)Ian W. Flinn (7 shared papers)R. Kanti (3 shared papers)
- Journals
- Blood (10 papers)Journal of Clinical Oncology (5 papers)Clinical Cancer Research (4 papers)Best Practice & Research Clinical Haematology (2 papers)Journal of the American Academy of Dermatology (1 paper)
- Partner nations
- United StatesMalaysiaIsrael
In The Last Decade
Michael R. Grever
43 papers receiving 3.3k citations
Michael R. Grever's Hit Papers
Peers
Comparison fields: 5 of 109
- Genetics 1.7k
- Pathology and Forensic Medicine 1.2k
- Immunology 942
- Hematology 350
- Toxicology 97
Countries citing papers authored by Michael R. Grever
This map shows the geographic impact of Michael R. Grever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Grever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Grever more than expected).
Fields of papers citing papers by Michael R. Grever
This network shows the impact of papers produced by Michael R. Grever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Grever. The network helps show where Michael R. Grever may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael R. Grever, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The National Cancer Institute: cancer drug discovery and development program. Hit paper breakdown → | 1992 | 657 |
| 2 | 1988 | 326 | |
| 3 | 2006 | 220 | |
| 4 | 1995 | 194 | |
| 5 | 2010 | 173 | |
| 6 | 2000 | 156 | |
| 7 | 2000 | 148 | |
| 8 | 2000 | 136 | |
| 9 | 1989 | 119 | |
| 10 | 2007 | 105 | |
| 11 | 2009 | 96 | |
| 12 | Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. | 1994 | 96 |
| 13 | 2005 | 88 | |
| 14 | 1990 | 82 | |
| 15 | 2007 | 73 | |
| 16 | Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse. | 1999 | 70 |
| 17 | 2004 | 62 | |
| 18 | 1999 | 54 | |
| 19 | 2009 | 52 | |
| 20 | 2006 | 42 |
About Michael R. Grever
Michael R. Grever is a scholar working on Genetics, Pathology and Forensic Medicine, Molecular Biology, Immunology and Oncology, having authored 43 papers that have together received 3.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (25 papers), Lymphoma Diagnosis and Treatment (14 papers), Acute Lymphoblastic Leukemia research (8 papers), Viral-associated cancers and disorders (5 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), Glycosylation and Glycoproteins Research (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Genetics (1.7k citations), Pathology and Forensic Medicine (1.2k citations), Immunology (942 citations), Hematology (350 citations) and Toxicology (97 citations). Michael R. Grever has collaborated with scholars based in United States, Malaysia and Israel. Frequent co-authors include Saul A. Schepartz, B A Chabner, Eric H. Kraut, Bertha A. Bouroncle, John C. Byrd, Neil E. Kay, Ian W. Flinn, R. Kanti, John C. Byrd and Georgia B. Vogelsang. Their work appears in journals such as Blood, Journal of Clinical Oncology, Clinical Cancer Research, Best Practice & Research Clinical Haematology and Journal of the American Academy of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.